Journal of Critical Care
Volume 23, Issue 4 , Pages 484-492, December 2008

Patient-specific decision modeling to guide the use of drotrecogin α (activated) in patients with severe sepsis☆

  • Daniel P. Schauer, MD, MSc

      Affiliations

    • Division of General Internal Medicine, University of Cincinnati Medical Center, Cincinnati, OH 45267-0535, USA
    • Institute for the Study of Health, University of Cincinnati Medical Center, Cincinnati, OH 45267-0535, USA
    • Corresponding Author InformationCorresponding author. University of Cincinnati Medical Center, PO Box 670535, Cincinnati, OH 45267-0535, USA. Tel.: +1 513 558 2048; fax: +1 513 558 2744.
    • ,
  • Anthony C. Leonard, PhD

      Affiliations

    • Division of General Internal Medicine, University of Cincinnati Medical Center, Cincinnati, OH 45267-0535, USA
    • Institute for the Study of Health, University of Cincinnati Medical Center, Cincinnati, OH 45267-0535, USA
    • ,
  • Richard W. Hornung, DrPH

      Affiliations

    • Cincinnati Children’s Hospital Medical Center, Cincinnati, OH 45224-3039, USA
    • ,
  • Joseph A. Johnston, MD, MSc

      Affiliations

    • Division of General Internal Medicine, University of Cincinnati Medical Center, Cincinnati, OH 45267-0535, USA
    • U.S. Outcomes Research, Eli Lilly, Indianapolis, IN 46285, USA
    • ,
  • Mark H. Eckman, MD, MS

      Affiliations

    • Division of General Internal Medicine, University of Cincinnati Medical Center, Cincinnati, OH 45267-0535, USA
    • Institute for the Study of Health, University of Cincinnati Medical Center, Cincinnati, OH 45267-0535, USA

published online 07 April 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Financial support for this study was provided entirely by an unrestricted educational grant from the Eli Lilly Company. The funding agreement ensured the authors' independence in designing the study, interpreting the data, writing, and publishing the report. The following author is employed by the sponsor: Joseph A. Johnston, MD, MSc.

PII: S0883-9441(08)00022-1

doi:10.1016/j.jcrc.2007.12.016

Journal of Critical Care
Volume 23, Issue 4 , Pages 484-492, December 2008

Article Tools

* Image Usage & Resolution